ROCKVILLE, MD., Feb. 23, 2016 -- The Regulatory Affairs Professionals Society (RAPS) today launched its global survey of regulatory professionals who work with healthcare and related products. RAPS' Scope of Practice & Compensation Survey of the Regulatory Profession, conducted every two years, is the largest and most comprehensive survey of professionals in this important field, vital to ensuring healthcare products are safe and effective.
Respondents work in the pharmaceutical, biotechnology and medical device industries, government agencies, academia, consultancies and other settings where regulatory expertise is needed. Those completing the 10–15-minute survey answer questions about their jobs, backgrounds and compensation, and all answers are kept confidential and anonymous. The results will be released this summer.
RAPS also is offering participants the option to receive free advance access to the results, as well as a chance to win one of four $250 (US) Amazon gift cards to be given away to respondents over the course of the next two months. In addition, those who have the Regulatory Affairs Certification (RAC) credential also receive one point toward their recertification requirement.
Regulatory professionals located anywhere in the world are invited to complete the survey online at http://ow.ly/YF1mc.
RAPS has conducted similar research on the regulatory profession for more than 25 years. The 2014 survey drew responses from more than 3,300 regulatory professionals in 62 countries. According to the resulting 2014 Scope of Practice & Compensation Report, regulatory professionals' salaries rose an average of 5.4% from 2012 to 2013. RAPS' analysis of the responses showed that job level, regulatory experience, highest-earned degree, total professional experience and having the RAC credential have significant influence on compensation.
The survey results will be very useful to regulatory professionals and talent managers wishing to benchmark salaries and compensation packages. It also provides insight to help RAPS track trends and drive greater awareness and understanding of the importance of the profession.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. http://www.RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245
[email protected]


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



